• Explore /
  • Poster
  • / LUX-Lung 6: Patient-reported outcomes (PROs) from a randomized open-label, phase III study in first-line advanced NSCLC patients (pts) harboring epidermal growth factor receptor (EGFR) mutations.

LUX-Lung 6: Patient-reported outcomes (PROs) from a randomized open-label, phase III study in first-line advanced NSCLC patients (pts) harboring epidermal growth factor receptor (EGFR) mutations.

Abstract Poster

Authors

Sarayut Geater

Sarayut Lucien Geater

Division of Respiratory and Respiratory Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Sarayut Lucien Geater , Caicun Zhou , Cheng-Ping Hu , Ji Feng Feng , Shun Lu , Yunchao Huang , Wei Li , Mei Hou , Jian Hua Shi , Kye Young Lee , Dan Massey , Juliane Lungershausen , Yang Shi , Victoria Zazulina , Yi Long Wu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01121393

Citation

J Clin Oncol 31, 2013 (suppl; abstr 8061)

DOI

10.1200/jco.2013.31.15_suppl.8061

Abstract #

8061

Poster Bd #

35A

Abstract Disclosures

Similar Posters

First Author: Yi Long Wu

First Author: Shun Lu

First Author: C. Zhou

First Author: Akito Hata